POROUS AND NON-POROUS BODIES
20170275196 · 2017-09-28
Inventors
Cpc classification
Y02P40/57
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
C03C11/007
CHEMISTRY; METALLURGY
C04B38/009
CHEMISTRY; METALLURGY
A61L27/3834
HUMAN NECESSITIES
C04B2235/95
CHEMISTRY; METALLURGY
C04B2235/5436
CHEMISTRY; METALLURGY
A61L27/54
HUMAN NECESSITIES
A61K45/06
HUMAN NECESSITIES
C03B19/1075
CHEMISTRY; METALLURGY
C03B19/102
CHEMISTRY; METALLURGY
C04B38/009
CHEMISTRY; METALLURGY
C03B19/1085
CHEMISTRY; METALLURGY
A61K9/167
HUMAN NECESSITIES
A61L2300/404
HUMAN NECESSITIES
A61L2430/02
HUMAN NECESSITIES
C01B25/32
CHEMISTRY; METALLURGY
C04B35/622
CHEMISTRY; METALLURGY
International classification
C03C11/00
CHEMISTRY; METALLURGY
A61K9/16
HUMAN NECESSITIES
A61L27/54
HUMAN NECESSITIES
A61K45/06
HUMAN NECESSITIES
Abstract
A method of manufacture of a powder comprising, or consisting essentially of, microspheres, the method comprising: providing a feed powder; and applying at least one spheroidisation flame to the powder. The powder may be suitable for use in medical and/or non-medical applications.
Claims
1. A method of manufacture of a powder comprising microspheres, the method comprising: providing a feed powder; and applying at least one spheroidisation flame to the powder.
2. The method according to claim 1 comprising the steps of: mixing the feed powder with one or more blowing agents to provide a mixture; and applying at least one spheroidisation flame to the mixture.
3. The method according to claim 1, wherein the feed powder comprises porous and/or non-porous particles.
4. The method according to claim 1, wherein the feed powder comprises substantially spherical and/or non-spherical particles.
5. The method according to claim 1, wherein the feed powder has an average particle size of from 30 μm to 500 μm.
6. The method according to claim 1 comprising flame-spraying spheroidisation.
7. The method according to claim 1, wherein the spheroidisation flame temperature is from 1900° C. to 3400° C.
8. The method according to claim 2, wherein the blowing agent has an average particle size of at least 5 μm and/or up to 500 μm.
9. The method according to claim 2, wherein the blowing agent comprises a carbonate or a sulphate.
10. The method according to claim 2, wherein the mixture is produced prior to applying the spheroidisation flame or at the same time as applying the spheroidisation flame.
11. The method according to claim 2, wherein the method comprises the step of soaking the feed powder in a solution containing the blowing agent(s).
12. The method according to claim 2, wherein the method comprises a washing step to remove residual blowing agent.
13. A method of manufacture of a powder comprising microspheres, the method comprising: manufacturing a first powder according to the method of claim 1; manufacturing at least one further powder according to the method of claim 1, wherein the at least one further powder contains particles having a different size distribution and/or a different porosity from the first powder; and mixing the first powder and the at least one further powder together.
14. A powder according to claim 1 comprising porous and/or non-porous microspheres.
15. The powder according to claim 14, wherein the microspheres have an average particle size of at least 30 μm and/or up to 500 μm.
16. The powder according to claim 14, wherein the microspheres comprise a resorbable composition or a non-resorbable composition.
17. The powder according to claim 14, wherein the microspheres comprise a glass, a glass-ceramic or a ceramic composition.
18. The powder according of claim 14, wherein the microspheres comprise a phosphate-based glass.
19. The powder according to claim 14, wherein the microspheres have a surface area per unit mass of at least 0.05 m.sup.2/g.
20. The powder according to claim 14, wherein the microspheres are porous and the average pore diameter is at least 10 μm and/or up to 100 μm.
21. The powder according to claim 14, wherein the microspheres have a total porosity of at least 40%.
22. The powder according to claim 14, wherein the powder comprises a mixture of a first powder and at least one further powder, and wherein the first powder comprises microspheres having a first size distribution and the further powder comprises microspheres having a different size distribution.
23. The powder according to claim 22, wherein the microspheres of the first powder are smaller than the microspheres of a second powder.
24. The powder according to claim 23, wherein the microspheres of the first powder have an average particle size of up to 200 μm and/or the microspheres of the second powder have an average particle size of more than 200 μm.
25. The powder according to claim 14, wherein the microspheres are coated and/or loaded with at least one active agent.
26. The powder according to claim 1, wherein the microspheres are coated and/or impregnated/doped with an anti-microbial agent.
27. A method for delivering an active agent comprising utilizing a powder according to claim 14.
28. The method according to claim 9, wherein the carbonate or the sulphate is a calcium carbonate, a strontium carbonate, or a sodium sulphate.
29. The powder according to claim 18, wherein the phosphate-based glass is selected from the group consisting of a calcium phosphate-based glass, a Bioglass®, hydroxyapatite, a tri-calcium phosphate (α-TCP), a β tri-calcium phosphate (β-TCP), a borosilicate glass, a borate glass, an apatite wollastonite, and a combination thereof.
30. The powder according to claim 19, wherein the microspheres have a surface area per unit mass of up to or at least 0.08 m.sup.2/g.
31. The powder according to claim 30, wherein the microspheres have a surface area per unit mass of up to or at least 0.12 m.sup.2/g.
32. The powder according to claim 31, wherein the microspheres have a surface area per unit mass of up to or at least 0.14 m.sup.2/g.
33. The powder according to claim 21, wherein the microspheres have a total porosity of at least 50%.
34. The powder according to claim 33, wherein the microspheres have a total porosity of at least 60%.
35. The powder according to claim 34, wherein the microspheres have a total porosity of at least 70%.
36. The powder according to claim 35, wherein the microspheres have a total porosity of at least 80%.
37. The powder according to claim 25, wherein the at least one active agent is selected from the list consisting of a pharmaceutically active agent, a biological cell, a growth factor, a protein, and a combination thereof.
38. The powder according to claim 37, wherein the biological cell is a stem cell.
39. The powder according to claim 26, wherein the anti-microbial agent is selected from the list consisting of silver, zinc, copper, and a combination thereof.
Description
[0077] In order that the invention may be well understood, it will now be described by way of example only with reference to the accompanying drawings in which:
[0078]
[0079]
[0080]
[0081]
[0082]
[0083]
[0084]
[0085]
[0086]
[0087]
[0088]
[0089]
[0090]
[0091]
[0092]
[0093]
[0094]
[0095]
[0096]
[0097]
[0098]
[0099]
[0100]
[0101]
[0102]
[0103]
[0104]
[0105]
[0106]
[0107]
[0108]
[0109]
[0110]
[0111]
[0112]
[0113]
[0114]
[0115]
[0116]
[0117]
[0118]
[0119]
[0120]
[0121]
[0122] The resorbable porous microspheres shown in
[0123] The resorbable porous microspheres shown in
[0124]
[0125] The porosity of the resorbable porous microspheres of the type shown in
TABLE-US-00001 TABLE 1 Average Apparent Closed pore Bulk (skeletal) Open porosity Total diameter density density porosity (vol %) porosity (μm) (g/mL) (g/mL) (vol %) (estimated) (vol %) 55 0.54 1.85 71 9 80
[0126] The resorbable porous microspheres shown in
[0127] The resorbable porous microspheres shown in
[0128]
[0129] The porosity of the resorbable porous microspheres of the type shown in
TABLE-US-00002 TABLE 2 Average Apparent Closed pore Bulk (skeletal) Open porosity Total diameter density density porosity (vol %) porosity (μm) (g/mL) (g/mL) (vol %) (estimated) (vol %) 56 0.58 1.66 65 14 79
[0130] The resorbable porous microspheres shown in
[0131] The resorbable porous microspheres shown in
[0132] The yield of resorbable porous microspheres manufactured as described above was in excess of 95%. As can be seen from
[0133]
[0134] The resorbable porous microspheres shown in
[0135] The resorbable porous microspheres shown in
[0136] The yield of resorbable porous microspheres manufactured as described above was in excess of 95%. As can be seen from
[0137]
[0138] Remnants of the blowing agent(s) used in the manufacture of porous resorbable microspheres according to the invention may be incorporated in the microspheres themselves. For instance, energy dispersive x-ray (EDX) analysis of a sample of porous resorbable microspheres according to the invention detected strontium within the microsphere composition, the strontium having come from the blowing agent, strontium carbonate, used in the manufacture of the microspheres. In some embodiments, the blowing agent(s) may be selected, in order to vary and/or finely control doping of the microsphere composition.
[0139] Advantageously, the methods of manufacture of the present invention may provide improved yields and/or uniformity of porous resorbable microspheres.
[0140]
[0141] As indicated by a first column 141, the specific surface area of the bulk, substantially non-porous calcium phosphate glass feed powder was found to be around 0.01 m.sup.2/g. As indicated by a second column 142, the specific surface area of porous resorbable microspheres of the type shown in
[0142]
[0143]
[0144] The data presented in Table 3 below illustrate the effect of washing the microspheres in an acetic acid solution. Two types of microspheres according to the invention were washed in an acetic acid solution. The first type of microspheres (A) were calcium phosphate glass microspheres, having a diameter of approximately 100 μm. The second type of microspheres (B) were calcium phosphate glass microspheres, having a diameter of approximately 100 μm. During manufacture, the ratio by weight of the blowing agent(s) to the calcium phosphate glass particles was different for the two types of microspheres (A and B).
[0145] The open porosity of the microspheres was measured pre- and post-wash. The closed porosity of the microspheres was measured pre- and post-wash. Hence, the total porosity of the microspheres could be calculated pre- and post-wash.
[0146] For the first type of microspheres (A), washing led to a slight increase in total porosity. Slight increases in the open porosity and/or the closed porosity contributed to the slight increase in total porosity.
[0147] For the second type of microspheres (B), washing resulted in a slightly larger increase in total porosity than for the first type of microspheres (A). The increase in total porosity of the second type of microspheres (B) arose, due to a large increase in open porosity, which was offset to some extent by a decrease in closed porosity.
TABLE-US-00003 TABLE 3 Open porosity Closed porosity Total porosity (vol %) (vol %) (vol %) Micro- Pre-acid Post-acid Pre-acid Post-acid Pre-acid Post-acid spheres wash wash wash wash wash wash A 71 72 (±2) 9 10 (±3) 80 82 (±1) B 65 76 (±2) 14 7 (±3) 79 83 (±2)
[0148] Without wishing to be bound by any theory, it is thought that washing the microspheres in acetic acid solution removes residual blowing agent(s) from the microspheres. The removal of residual blowing agent(s) may contribute at least partially to an increase in total porosity of the microspheres. Pores that were closed or obstructed due to the presence of residual blowing agent(s) may be opened as a result of the washing.
[0149]
[0150]
[0151]
[0152]
[0153]
[0154]
[0155]
[0156]
[0157]
[0158]
[0159]
[0160]
[0161]
[0162]
[0163]
[0164]
[0165]
[0166]
[0167]
[0168]
[0169]
[0170]
[0171] A better packing efficiency may be achieved by providing microspheres of a plurality of different sizes.
[0172]
[0173] A powder comprising resorbable porous microspheres according to the invention may contain any number of types of porous resorbable microspheres mixed in any ratio. Accordingly, a powder may be produced having particles of more than one distinct particle size distribution and/or porosity.
[0174] The powder may have any particle size distribution. For instance, the powder may have a monomodal, bimodal, trimodal, tetramodal, pentamodal or hexamodal particle size distribution. Different particle size distributions may be better suited for different applications.
[0175] The irregularly-shaped space could be, for example, a space between two sections of bone or a defect or void within a bone.
[0176] One application for resorbable porous microspheres of the invention is in bone tissue regeneration, e.g. in the treatment of osteoporosis or other bone resorption disorders.
[0177] For this application, calcium phosphate microspheres according to the invention may be loaded with autologous stem cells (or other cell types) and/or other biological components. The resorbable porous microspheres of the invention could be used as a bone graft substitute.
[0178] Osteoporosis and fragility fractures are a major problem worldwide, particularly in countries with aging populations. As a consequence, there is an ever-growing need for long-term orthopaedic care.
[0179] The present invention may help to facilitate a shift from tissue repair to tissue regeneration. By facilitating a shift from tissue repair to tissue regeneration, the growth rate of the need for long-term orthopaedic care may be reduced.
[0180] Across Europe, an estimated four million new fractures occur per year (around eight fractures each minute or one every eight seconds). The total direct cost of these fractures has been estimated at 31.7 billion, which is forecast to increase to
76.7 billion by 2050 based on anticipated changes in the demography of Europe.
[0181] In the UK, the annual combined healthcare and social cost for fractures in bones weakened by osteoporosis is nearly £1.73 billion.
[0182] In the UK, currently nearly 20 million people are aged 50 or more. This is predicted to increase to 25 million by 2020. Over 60,000 hip, 50,000 wrist and 120,000 vertebral osteoporosis-related fractures occur each year in the UK. According to the National Osteoporosis Society, recent trends suggest that hip fracture rates will increase to 117,000 by 2016.
[0183] In 2001, combined NHS and social care costs for a single hip fracture in the UK were estimated to be £20000.
[0184] Each year fractures in patients aged 60 and over account for more than two million hospital bed days in England alone. Around 30% of over 65 year olds living in the community will fall each year (increasing to 42% for the over 75 age group), while over 60% of people in care homes fall each year.
[0185] Usually, treatment is not administered until after a person, e.g. an elderly person with osteoporosis, has suffered a broken bone. Advantageously, treatment using the present invention may be administered prior to any fractures (or any further fractures) occurring, in order to reduce the likelihood of an individual suffering a fracture in a bone weakened by osteoporosis. Apart from patient benefits, this may also lead to significant social and healthcare cost savings.
[0186] In an example embodiment of the invention, an individual may be identified as having or being at risk of having osteoporosis. For instance, the individual may have suffered (or be at risk of suffering) a fracture, e.g. an osteoporotic compression fracture. The individual may then have an examination, typically an x-ray examination, in order to identify any regions of resorbed osteoporotic bone. The examination, e.g. the x-ray examination, may comprise a whole-body scan. A whole-body scan may be able to provide information on overall and local bone mineral content (BMC) and bone mineral density (BMD).
[0187] Autologous stem cells may then be isolated from the individual. The autologous stem cells isolated from the individual are then loaded into bio-resorbable porous microspheres according the invention.
[0188] The bio-resorbable porous microspheres loaded with the autologous stem cells may then be injected into the identified region(s) of resorbed osteoporotic bone. Typically, this may involve only a minimally invasive surgical procedure using needles or cannulae. Accordingly, the individual may be treated as a hospital day-case patient.
[0189] The bio-resorbable porous microspheres may dissolve over time within the body, without causing any harm to the individual. The autologous stem cells will act to promote regeneration of bone tissue, thereby strengthening the identified region(s) of resorbed osteoporotic bone. Hence, the likelihood of the individual suffering a bone fracture may be reduced.
[0190] An individual may be found to have a region of resorbed osteoporotic bone. The region of resorbed osteoporotic bone could be in any part of the individual's skeleton, e.g. the spine, femur, hip, ankle or wrist. A syringe or cannula may be used to inject porous bio-resorbable microspheres loaded with autologous stem cells isolated from the individual into the region of resorbed osteoporotic bone.
[0191] It will be appreciated that the porous resorbable microspheres of the invention may provide an osteoporotic fracture prevention prophylactic. Advantageously, this preventative treatment may be delivered non-invasively or via a minimally invasive surgical procedure.
[0192] While dissolving within the body, the bio-resorbable porous microspheres may release active and/or therapeutic agents, e.g. ions, other than, or as well as, cells such as autologous stem cells.
[0193] The applicant has carried out experiments in which human mesenchymal stem cells (hMSC) have been loaded into porous calcium phosphate glass microspheres according to the invention. Porous resorbable microspheres comprising pores having larger diameters may be preferred for applications in which the porous resorbable microspheres are loaded with stem cells.
[0194]
[0195] Porous microspheres according to the invention may be loaded with agents other than stem cells, e.g. cells, growth factors, proteins or pharmaceutically active agents.
[0196] The porous microspheres of the invention may have utility in the treatment of fractures, e.g. osteoporotic fractures such as osteoporotic vertebral fractures.
[0197] The porous microspheres of the invention may find utility as a bone graft material.
[0198] Application of the porous resorbable microspheres of the invention is not limited to bone regeneration.
[0199] The porous resorbable microspheres may be loaded with chemical or biological drugs or other active agents for release into the human or animal body.
[0200] The invention may also have utility in non-biomedical applications. An example of a non-biomedical application is filtration and separation.
[0201] For instance, porous microspheres may be used to separate a mixture of large and small molecules. An initial mixture of larger molecules and smaller molecules is fed to a gel filtration resin comprising a plurality of porous microspheres according to the invention. The smaller molecules may be “included” (i.e. be small enough to pass into and through the pores of porous microspheres), while the larger molecules may be “excluded” (i.e. be too large to enter the pores of the porous microspheres 203). Hence, the larger molecules 201 may be eluted before the smaller molecules 202.
[0202] Another potential use for porous resorbable microspheres according to the invention is as a replacement for “microbeads” which are found in many beauty and cleaning products.
[0203] Microbeads are typically made from plastic and are included in products such as shower gel, face washes, toothpaste and cleaning products for their abrasive qualities.
[0204] A problem with microbeads is that typically they may be too small to be filtered out at water treatment plants and consequently may end up in lakes and rivers. The plastic may soak up toxins and be eaten by fish and other creatures. In this way, there is a concern that toxins may build up in the food chain and eventually be consumed by humans.
[0205] Porous resorbable microspheres according to the present invention may be used as a substitute for microbeads. They could provide the required abrasive qualities before dissolving harmlessly into the environment, e.g. in a lake or river, in a fish or other creature or in a human or animal at the top of the food chain.
[0206] Other potential applications for microspheres according to the invention may include: use as a feedstock for additive manufacturing; filtration; separation; fluid, e.g. water, purification; beauty and personal care products such as cosmetics, shower gel and face wash; laundry and cleaning products; or use in applications requiring a lightweight low thermal expansion and low conductivity material.
[0207] For example, porous and/or non-porous microspheres, e.g. glass or glass-ceramic bulk (i.e. non-porous) and/or porous microspheres according to the invention may be used in combination with other particles or bodies such as microspheres. Such other particles or bodies may comprise polymer microspheres.
[0208] In an example embodiment, porous and/or non-porous microspheres according to the invention may be used in combination with natural or synthetic polymer microspheres. The utilisation of natural or synthetic polymer microspheres may help to achieve control over drug and/or biological component release. Additionally or alternatively, the natural or synthetic polymer microspheres may be utilised to deliver alternate drugs or biological components directly to sites of interest.
[0209] In another example embodiment, combining fast-resorbing microspheres, e.g. glass microspheres such as calcium phosphate microspheres, according to the invention with polymer microspheres could be used to achieve control over the polymer degradation profiles and vice versa—acidic release from polymer microspheres could be used to control release from the glass microspheres.
[0210] In another example embodiment, microspheres according to the invention, e.g. bulk (i.e. non-porous) and/or porous glass or glass-ceramic microspheres, may be coated at least partially with one or more resorbable (natural or synthetic) polymers to gain improved control over release of components carried by, e.g. encapsulated within and/or coated on, the microspheres.
[0211] Gaining control of particle geometry can be critical for additive manufacturing (e.g. 3D printing). Accordingly, microspheres according to the invention may be well suited for use in a feedstock for an additive manufacturing process, due to their uniformity and/or sphericity.
[0212] Currently, for instance, there is significant interest in possible additive manufacturing of biological materials or components, but it is proving extremely difficult to achieve and/or optimise. In an example embodiment, porous microspheres according to the invention may be loaded with one or more biological components (or non-biological entities) of interest to provide a feedstock. The feedstock may then be supplied to a 3D printer or other additive manufacturing device operable to produce a component having a desired geometry. With careful control over the composition of the microspheres, e.g. glass formulations of the microspheres, the component could then be engineered to degrade away (over time and/or in situ), leaving behind the incorporated biological components.
[0213] Microspheres according to the present invention may be utilised in separation and/or filtration applications.
[0214] In an example, it is envisaged that microspheres according to the invention may have utility in filtration devices within industrial applications (such as desalination plants), e.g. to remove heavy metals or bacteria.
[0215]
[0216]
[0217] The solution passed through the micropipette much quicker in the experiment shown in
[0218] It is noted that in both
[0219]
[0220] In contrast with the experiments shown in
[0221] Accordingly, the porous microspheres according to the invention are capable of separating and retaining the dye from the water. This result suggests that with careful control over the chemistry and/or composition of the porous microspheres, e.g. porous glass or glass-ceramic microspheres, the internal surfaces of the porous microspheres could be adapted to filter out specific entities, e.g. heavy metals or other unwanted entities in solutions.
[0222]